Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
Banerji, Udai, Prof, van Herpen, Carla M L, Prof, Saura, Cristina, MD, Thistlethwaite, Fiona, MD, Lord, Simon, MD, Moreno, Victor, MD, Macpherson, Iain R, MD, Boni, Valentina, MD, Rolfo, Christian, Prof, de Vries, Elisabeth G E, Prof, Rottey, Sylvie, Prof, Geenen, Jill, MD, Eskens, Ferry, MD, Gil-Martin, Marta, MD, Mommers, Ellen C, PhD, Koper, Norbert P, PhD, Aftimos, Philippe, MD
Published in The lancet oncology (01.08.2019)
Published in The lancet oncology (01.08.2019)
Get full text
Journal Article
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial
Bonvalot, Sylvie, PhD, Rutkowski, Piotr L, Prof, Thariat, Juliette, Prof, Carrère, Sébastien, MD, Ducassou, Anne, MD, Sunyach, Marie-Pierre, MD, Agoston, Peter, MD, Hong, Angela, MBBS, Mervoyer, Augustin, MD, Rastrelli, Marco, MD, Moreno, Victor, MD, Li, Rubi K, MD, Tiangco, Béatrice, MD, Herraez, Antonio Casado, MD, Gronchi, Alessandro, MD, Mangel, László, MD, Sy-Ortin, Teresa, MD, Hohenberger, Peter, Prof, de Baère, Thierry, Prof, Le Cesne, Axel, MD, Helfre, Sylvie, MD, Saada-Bouzid, Esma, MD, Borkowska, Aneta, MD, Anghel, Rodica, MD, Co, Ann, MD, Gebhart, Michael, Prof, Kantor, Guy, Prof, Montero, Angel, MD, Loong, Herbert H, MD, Vergés, Ramona, MD, Lapeire, Lore, MD, Dema, Sorin, MD, Kacso, Gabriel, MD, Austen, Lyn, MD, Moureau-Zabotto, Laurence, MD, Servois, Vincent, MD, Wardelmann, Eva, Prof, Terrier, Philippe, MD, Lazar, Alexander J, MD, Bovée, Judith V M G, Prof, Le Péchoux, Cécile, MD, Papai, Zsusanna, Prof
Published in The lancet oncology (01.08.2019)
Published in The lancet oncology (01.08.2019)
Get full text
Journal Article
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Sandhu, Shahneen K, MD, Schelman, William R, MD, Wilding, George, MD, Moreno, Victor, MD, Baird, Richard D, PhD, Miranda, Susana, BSc, Hylands, Lucy, BSc, Riisnaes, Ruth, FIBMS, Forster, Martin, PhD, Omlin, Aurelius, MD, Kreischer, Nathan, MSc, Thway, Khin, MD, Gevensleben, Heidrun, MD, Sun, Linda, PhD, Loughney, John, PhD, Chatterjee, Manash, PhD, Toniatti, Carlo, PhD, Carpenter, Christopher L, MD, Iannone, Robert, MD, Kaye, Stan B, Prof, de Bono, Johann S, Prof, Wenham, Robert M
Published in The lancet oncology (01.08.2013)
Published in The lancet oncology (01.08.2013)
Get full text
Journal Article